0001209191-23-058807.txt : 20231215
0001209191-23-058807.hdr.sgml : 20231215
20231215170139
ACCESSION NUMBER: 0001209191-23-058807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARBARI SHARON
CENTRAL INDEX KEY: 0001240499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 231491202
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER NAME:
FORMER CONFORMED NAME: BARBARI SHARON SURREY
DATE OF NAME CHANGE: 20030610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 ROUTE 202/206 N., SUITE 301
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 685 ROUTE 202/206 N., SUITE 301
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-13
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001240499
BARBARI SHARON
C/O VYNE THERAPEUTICS INC.
685 ROUTE 202/206 N, SUITE 301
BRIDGEWATER
NJ
08807
1
0
0
0
0
Stock Option (right to buy)
2.70
2023-12-13
4
A
0
20000
0.00
A
2033-12-12
Common Stock
20000
20000
D
Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.
/s/ Mutya Harsch, attorney-in-fact for Sharon Barbari
2023-12-15